Výpis publikací

2019

1. Bevacizumab as therapeutic option for recurrent nasal bleeding in hereditary hemorrhagic telangiectasia.

   STUDECKÁ, Eva, Jana NEUWIRTHOVÁ, Pavla URBÁNKOVÁ a Břetislav GÁL. Bevacizumab as therapeutic option for recurrent nasal bleeding in hereditary hemorrhagic telangiectasia. In 18th Czech-German ENT Days; 19.-21.9.,Pardubice, Czech Republic. 2019.

   Podrobněji: https://is.muni.cz/publication/1628072/cs